Skip to main content
SpringerLink
Log in

Automated covariate selection and Bayesian model averaging in population PK/PD models

  • Published:
Journal of Pharmacokinetics and Pharmacodynamics Aims and scope Submit manuscript

Abstract

We illustrate the use of ‘reversible jump’ MCMC to automate the process of covariate selection in population PK/PD analyses. The output from such an approach can be used not only to determine the ‘best’ covariate model for each parameter, but also to formally measure the spread of uncertainty across all possible models, and to average inferences across a range of ‘good’ models. We examine the substantive impact of such model averaging compared to conditioning inferences on the ‘best’ model alone, and conclude that clinically significant differences between the two approaches can arise. The illustrative data that we consider pertain to the drug vancomycin in 59 neonates and infants, and all analyses are conducted using the WinBUGS software with newly developed ‘Jump’ interface installed.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Akaike H (1974). A new look at statistical model identification. IEET T Automat Contr AU-19: 716–722

    Article  Google Scholar 

  2. Vaida F and Blanchard S (2005). Conditional Akaike information for mixed-effects models. Biometrika 92: 351–370

    Article  Google Scholar 

  3. Lavielle M and Mentré F (2007). Estimation of population pharmacokinetic parameters of saquinavir in HIV patients with the MONOLIX software. J Pharmacokinet Pharmacodyn 34: 229–249

    Article  PubMed  CAS  Google Scholar 

  4. Longford NT (2005). Editorial: model selection and efficiency—is ‘Which model ...?’ the right question?. J R Statist Soc A 168: 469–472

    Article  Google Scholar 

  5. Hoeting JA, Madigan D, Raftery AE and Volinsky CT (1999). Bayesian model averaging: a tutorial. Stat Sci 14: 382–417

    Article  Google Scholar 

  6. Green PJ (1995). Reversible jump Markov chain Monte Carlo computation and Bayesian model determination. Biometrika 82: 711–732

    Article  Google Scholar 

  7. Lunn DJ, Thomas A, Best N and Spiegelhalter D (2000). WinBUGS—a Bayesian modelling framework: concepts, structure, and extensibility. Stat Comput 10: 325–337

    Article  Google Scholar 

  8. Spiegelhalter D, Thomas A, Best N, Lunn D (2003) WinBUGS user manual, version 1.4. Medical Research Council Biostatistics Unit, Cambridge

  9. Lunn DJ, Best N, Whittaker J (2005) Generic reversible jump MCMC using graphical models. Technical Report EPH-2005-01, Department of Epidemiology and Public Health, Imperial College London, UK

  10. Lunn DJ, Whittaker JC and Best N (2006). A Bayesian toolkit for genetic association studies. Genet Epidemiol 30: 231–247

    Article  PubMed  Google Scholar 

  11. Grimsley C and Thomson AH (1999). Pharmacokinetics and dose requirements of vancomycin in neonates. Arch Dis Child Fetal Neonatal Ed 81: F221–F227

    Article  PubMed  CAS  Google Scholar 

  12. Bernardo JM and Smith AFM (1994). Bayesian theory. John Wiley & Sons, New York

    Google Scholar 

  13. Wakefield J and Bennett J (1996). The Bayesian modeling of covariates for population pharmacokinetic models. J Am Statist Ass 91: 917–927

    Article  Google Scholar 

  14. Metropolis N, Rosenbluth AW, Rosenbluth MN, Teller AH and Teller E (1953). Equations of state calculations by fast computing machines. J Chem Phys 21: 1087–1091

    Article  CAS  Google Scholar 

  15. Hastings WK (1970). Monte Carlo sampling-based methods using Markov chains and their applications. Biometrika 57: 97–109

    Article  Google Scholar 

  16. Lunn DJ, Best N, Thomas A, Wakefield J and Spiegelhalter D (2002). Bayesian analysis of population PK/PD models: general concepts and software. J Pharmacokinet Pharmacodyn 29: 271–307

    Article  PubMed  CAS  Google Scholar 

  17. Lunn DJ, Wakefield J, Thomas A, Best N, Spiegelhalter D (1999) PKBugs user guide version 1.1. Dept. Epidemiology and Public Health, Imperial College School of Medicine, London

  18. Lunn D (2006) WinBUGS ‘Jump’ Interface: Beta-Release User Manual. Dept. Epidemiology and Public Health, Imperial College School of Medicine, London

  19. Brooks SP and Giudici P (1999). Convergence assessment for reversible jump MCMC simulations. In: Bernardo, JM, Berger, JO, Dawid, AP and Smith, AFM (eds) Bayesian statistics 6, pp 733–742. Oxford University Press, Oxford

    Google Scholar 

  20. Wakefield JC, Smith AFM, Racine-Poon A and Gelfand AE (1994). Bayesian analysis of linear and non-linear population models by using the Gibbs sampler. Appl Stat 43: 201–221

    Article  Google Scholar 

  21. Kang D, Verotta D (2007) Reversible jump Markov chain Monte Carlo for deconvolution. J Pharmacokinet Pharmacodyn doi:10.1007/s10928-006-9045-x

Download references

Author information

Authors and Affiliations

  1. Medical Research Council Biostatistics Unit, Institute of Public Health, University Forvie Site, Robinson Way, Cambridge, CB2 0SR, UK

    David J. Lunn

Authors
  1. David J. Lunn
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to David J. Lunn.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lunn, D.J. Automated covariate selection and Bayesian model averaging in population PK/PD models. J Pharmacokinet Pharmacodyn 35, 85–100 (2008). https://doi.org/10.1007/s10928-007-9077-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10928-007-9077-x

Keywords

Search

Navigation